Skip to main content
Signal8

Weinand Dieter

SEC insider (Form 3/4/5 filer). CIK 0001744419. Director at Replimune Group, Inc. (REPL) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Apr 1, 2026. Located in WOBURN, MA.

Companies Weinand Dieter has filed insider reports for

  • Replimune Group, Inc. (REPL): Director
  • Coya Therapeutics, Inc. (COYA): Director
Weinand Dieter profile photo

Weinand Dieter

CIK: 0001744419

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Replimune Group, Inc. logo
REPL

Replimune Group, Inc.

Director
Coya Therapeutics, Inc. logo
COYA

Coya Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Replimune Group, Inc. logo
    REPL

    Replimune Group, Inc.

    Apr 1, 2026
    Award

    Stock Option (right to buy)

    Direct
    44.5K shares-
  • Coya Therapeutics, Inc. logo
    COYA

    Coya Therapeutics, Inc.

    Jan 2, 2026
    Award

    Stock Option (right to buy)

    Direct
    10K shares-
  • Replimune Group, Inc. logo
    REPL

    Replimune Group, Inc.

    Apr 1, 2025
    Award

    Stock Option (right to buy)

    Direct
    32K shares-
  • Coya Therapeutics, Inc. logo
    COYA

    Coya Therapeutics, Inc.

    Feb 25, 2025
    Award

    Stock Option (right to buy)

    Direct
    5K shares-
  • Coya Therapeutics, Inc. logo
    COYA

    Coya Therapeutics, Inc.

    Jan 1, 2025
    Award

    Stock Option (right to buy)

    Direct
    5K shares-

1-5 of 5